Hepatitis refers to inflammation of the liver, which is commonly caused by viral infections. There are 5 main types of hepatitis viruses - A, B, C, D and E. Hepatitis A and E are typically spread through contaminated food or water, while hepatitis B, C and D usually occur through contact with infected body fluids. Acute hepatitis may present with few or no symptoms, while chronic hepatitis can progress to fibrosis, cirrhosis or liver cancer over many years if left untreated. Diagnosis involves physical exam, imaging, liver function tests and blood tests to detect viral antibodies.
This document discusses different types of viral hepatitis, including hepatitis A, B, C, D, E, F, and G. It provides details on the viruses that cause each type, their transmission routes, incubation periods, clinical presentations, and potential outcomes. The key points are that hepatitis viruses are a major global cause of liver inflammation and disease, and that while some cause only acute illness, others can develop into chronic conditions and even liver cancer if left untreated.
The document discusses different types of viral hepatitis, including Hepatitis A, B, C, D, and E. It provides details on the classification, transmission, pathogenesis, clinical features, diagnosis, and prevention of each viral hepatitis type. It notes that Hepatitis A and E are typically transmitted through the fecal-oral route due to contaminated food or water, while Hepatitis B, C and D are transmitted through blood or bodily fluids. Vaccines exist for Hepatitis A and B but not the others.
Hepatitis E is caused by the hepatitis E virus (HEV) and spreads primarily through contaminated drinking water. It was first identified during an outbreak in India in 1955. Dr. Balayan helped discover HEV in 1983 while investigating an outbreak in Central Asia. HEV has three overlapping genes and infects the liver, with symptoms including jaundice. Pregnant women are particularly at risk, with mortality rates as high as 20% in the third trimester. Prevention focuses on proper sanitation and hygiene. A vaccine has been developed in China but is not yet widely available.
The document discusses hepatitis A, a viral infection that causes inflammation of the liver. It begins by describing the epidemiology of hepatitis A, including that it is more common in areas with poor sanitation. It then covers the hepatitis A virus itself, noting it is a small RNA virus transmitted via the fecal-oral route. For prevention, the document recommends measures like handwashing and vaccination.
Hepatitis viruses include Hepatitis A, B, C, D, E, and G. Hepatitis A virus is transmitted through the fecal-oral route and causes an acute infection. Hepatitis B virus is transmitted through blood or bodily fluids and can cause either an acute or chronic infection. Hepatitis C virus is transmitted through blood exposure and commonly causes a chronic infection. Prevention strategies include vaccination, immunoglobulin treatment, and screening of blood donors.
Viral hepatitis refers to liver infection caused by different viral agents including hepatitis A, B, C, D, E, and G viruses. Hepatitis A virus (HAV) causes the disease hepatitis A, which presents with non-specific symptoms like fever, fatigue, nausea and then jaundice. It is usually self-limiting but can incapacitate patients for weeks. HAV spreads primarily through the fecal-oral route. Control measures include handwashing, sanitary disposal of waste, and vaccination.
Hepatitis D is caused by the Hepatitis D virus (HDV) and requires co-infection with Hepatitis B. HDV is found worldwide but prevalence is highest in Italy, the Middle East, Central Asia, West Africa, and South America. HDV transmission occurs through the same routes as HBV, except it is not sexually transmitted. Infection depends on HBV replication as HBV provides the envelope for HDV. HDV infection is diagnosed through an HDV antibody test.
This document discusses different types of viral hepatitis, including hepatitis A, B, C, D, E, F, and G. It provides details on the viruses that cause each type, their transmission routes, incubation periods, clinical presentations, and potential outcomes. The key points are that hepatitis viruses are a major global cause of liver inflammation and disease, and that while some cause only acute illness, others can develop into chronic conditions and even liver cancer if left untreated.
The document discusses different types of viral hepatitis, including Hepatitis A, B, C, D, and E. It provides details on the classification, transmission, pathogenesis, clinical features, diagnosis, and prevention of each viral hepatitis type. It notes that Hepatitis A and E are typically transmitted through the fecal-oral route due to contaminated food or water, while Hepatitis B, C and D are transmitted through blood or bodily fluids. Vaccines exist for Hepatitis A and B but not the others.
Hepatitis E is caused by the hepatitis E virus (HEV) and spreads primarily through contaminated drinking water. It was first identified during an outbreak in India in 1955. Dr. Balayan helped discover HEV in 1983 while investigating an outbreak in Central Asia. HEV has three overlapping genes and infects the liver, with symptoms including jaundice. Pregnant women are particularly at risk, with mortality rates as high as 20% in the third trimester. Prevention focuses on proper sanitation and hygiene. A vaccine has been developed in China but is not yet widely available.
The document discusses hepatitis A, a viral infection that causes inflammation of the liver. It begins by describing the epidemiology of hepatitis A, including that it is more common in areas with poor sanitation. It then covers the hepatitis A virus itself, noting it is a small RNA virus transmitted via the fecal-oral route. For prevention, the document recommends measures like handwashing and vaccination.
Hepatitis viruses include Hepatitis A, B, C, D, E, and G. Hepatitis A virus is transmitted through the fecal-oral route and causes an acute infection. Hepatitis B virus is transmitted through blood or bodily fluids and can cause either an acute or chronic infection. Hepatitis C virus is transmitted through blood exposure and commonly causes a chronic infection. Prevention strategies include vaccination, immunoglobulin treatment, and screening of blood donors.
Viral hepatitis refers to liver infection caused by different viral agents including hepatitis A, B, C, D, E, and G viruses. Hepatitis A virus (HAV) causes the disease hepatitis A, which presents with non-specific symptoms like fever, fatigue, nausea and then jaundice. It is usually self-limiting but can incapacitate patients for weeks. HAV spreads primarily through the fecal-oral route. Control measures include handwashing, sanitary disposal of waste, and vaccination.
Hepatitis D is caused by the Hepatitis D virus (HDV) and requires co-infection with Hepatitis B. HDV is found worldwide but prevalence is highest in Italy, the Middle East, Central Asia, West Africa, and South America. HDV transmission occurs through the same routes as HBV, except it is not sexually transmitted. Infection depends on HBV replication as HBV provides the envelope for HDV. HDV infection is diagnosed through an HDV antibody test.
Hepatitis is inflammation of the liver that can be caused by viruses, bacteria, toxins, and drugs. There are several types of hepatitis defined by their causes, which include viral types A, B, C, D, and E transmitted by fecal-oral, blood, or sexual contact; alcoholic hepatitis caused by heavy alcohol use; and toxic hepatitis due to toxins, drugs, or chemicals. Diagnosis involves liver enzyme and function tests to determine the presence and extent of liver damage. Treatment depends on the type but may include antiviral medications, immune system modulators, and avoiding further liver damage.
This document provides information about Hepatitis A Virus. It discusses that Hepatitis A is a picornavirus that infects humans and is transmitted through the fecal-oral route. While symptoms are usually mild and self-limiting, there can be complications in some cases including fulminant hepatitis. Prevention strategies include vaccination, improved sanitation and hygiene. The vaccine is effective but underutilized in many developing countries due to cost considerations.
The liver performs many essential functions, including producing chemicals and storing vitamins and minerals. Hepatitis refers to inflammation of the liver, which can be caused by viruses, alcohol, medications, and other toxins. The most common types of viral hepatitis are types A, B, and C. Hepatitis C is a serious disease that can lead to cirrhosis or liver cancer if not treated. While some people have no symptoms, others experience fatigue, abdominal pain, and jaundice. Treatment aims to eliminate the hepatitis C virus and prevent further liver damage.
Hepatitis is inflammation of the liver that can be caused by viral or non-viral factors. The major types of viral hepatitis are Hepatitis A, B, C, D, and E viruses. Hepatitis A virus causes an acute, self-limiting form of hepatitis transmitted through the fecal-oral route. Hepatitis B virus can cause both acute and chronic hepatitis and is transmitted through blood and body fluids. It is responsible for over 90% of viral hepatitis cases and is an important public health issue. Hepatitis C, D and E viruses also cause hepatitis through blood transmission but to varying degrees.
The document discusses several hepatitis viruses including types A, D, E, and G. It provides details on the classification, morphology, transmission, epidemiology, clinical manifestation, laboratory diagnosis, treatment and prevention of each virus. Hepatitis A virus causes infectious hepatitis and is transmitted via the fecal-oral route. Hepatitis D virus is defective and requires hepatitis B virus for replication. It causes more severe disease than hepatitis B alone. Hepatitis E virus causes enterically transmitted hepatitis epidemics in certain regions. Hepatitis G virus does not appear to cause hepatitis but may co-infect with other viruses like HIV.
Hepatitis is inflammation of the liver that is usually caused by a viral infection, including hepatitis A, B, C, D, E, and G viruses. The document discusses each type of viral hepatitis in terms of its discovery date, prevalence, transmission routes, prevention methods, and available treatments. For most types, vaccination and practicing good hygiene are emphasized for prevention, while treatment varies depending on the viral agent and may involve antiviral medications.
This document provides information about hepatitis C virus (HCV) including its structure, genome, genotypes, epidemiology, transmission, pathogenesis, diagnosis, and management. It discusses:
- HCV has a single-stranded RNA genome within the Flaviviridae family. It exists as different genotypes that determine treatment response.
- HCV is a major cause of liver disease worldwide, with transmission primarily through blood exposure. Diagnosis involves antibody and RNA testing.
- Treatment aims to eradicate HCV and involves pegylated interferon and ribavirin combinations. Response is monitored via viral load decline. Adverse effects require monitoring and management. New direct-acting antivirals are improving treatment outcomes.
A 45-year-old woman presented with fatigue, weakness, and appetite loss. Laboratory tests found elevated liver enzymes, bilirubin, and HCV RNA. A liver biopsy showed severe inflammation and fibrosis. She was diagnosed with hepatitis C based on her history of blood transfusion and laboratory results. Treatment with antiviral therapy is recommended to prevent further liver damage from the hepatitis C infection.
This document provides information about Hepatitis C, including how it is transmitted, symptoms, diagnosis, treatment, and prevention. Some key points:
- Hepatitis C is a contagious liver disease caused by the hepatitis C virus that can range from mild to serious and lifelong.
- It is mostly transmitted through exposure to infectious blood, such as through contaminated medical equipment or injecting drug use.
- Most infected people do not show symptoms, though some may experience fatigue, abdominal pain, and jaundice. Chronic infection can lead to cirrhosis or liver cancer.
- Diagnosis involves antibody and RNA testing to confirm. People at high risk should be screened.
- Treatment involves antiviral therapy with
Hepatitis C is a contagious liver disease that can range from a mild illness lasting a few weeks to a serious lifelong condition. Acute hepatitis C occurs within the first 6 months of exposure and often leads to chronic infection. Chronic hepatitis C can last a lifetime and significantly damage the liver, possibly causing cirrhosis or liver cancer. The virus is primarily spread through contact with infected blood and affects an estimated 3.2 million Americans, with baby boomers most at risk. While treatment is very effective at clearing the virus, hepatitis C was responsible for over 350,000 deaths worldwide in recent years.
Spread the Awareness about #Hepatitis with us on this World Hepatitis Day!
#28July #WorldHepatitisDay
*Free Shipping on all US Orders - Coupon Code "FS99"
www.OffshoreCheapMeds.co
The document summarizes hepatitis E virus (HEV), including its virology, epidemiology, transmission, clinical presentation, diagnosis, management, and prevention. HEV is an RNA virus endemic in Asia and causes acute, self-limiting hepatitis but can develop into acute liver failure, especially in pregnant women. It is transmitted primarily through contaminated food or water. Acute hepatitis E presents with jaundice and liver enzyme abnormalities and typically resolves within 1-6 weeks, though complications can include acute liver failure, chronic hepatitis may occur in immunosuppressed patients. Pregnant women are at higher risk for more severe outcomes. Management involves supportive care and chronic hepatitis may be treated with antivirals.
This document provides an introduction and overview of hepatitis classification and viruses. It discusses the following key points:
1. Hepatitis is defined as inflammation of the liver caused by viruses. There are 5 main hepatitis viruses - Hepatitis A, B, C, D, and E viruses. Hepatitis B is the only DNA virus, while the others are RNA viruses.
2. The viruses are classified based on their nucleic acid and transmitted through different routes. Hepatitis A and E are transmitted via the fecal-oral route, while Hepatitis B, C, D are blood-borne.
3. Each virus is then discussed in more detail covering features like morphology, epidemiology, pathogenesis, diagnosis, and
Hepatitis B is a viral infection that affects the liver and can become chronic. It is transmitted through bodily fluids and can range from asymptomatic to life-threatening. Around 1 million people die each year from hepatitis B complications like cirrhosis and liver cancer. While there is no cure for chronic hepatitis B, antiviral treatments can suppress the virus and prevent further liver damage. Vaccination provides highly effective protection against the disease.
Hepatitis E is a viral infection caused by the Hepatitis E virus (HEV). It is transmitted through contaminated water or food supplies and causes acute viral hepatitis. The incubation period is 2-9 weeks. Infection results in self-limiting acute hepatitis lasting several weeks, followed by recovery with no chronic cases reported. Pregnant women can experience a fulminating form with potential complications. Diagnosis is made through anti-HEV antibody levels. Prevention involves food and water hygiene precautions. There is no vaccine or specific treatment.
The presentation is about the disease, hepatitis, its causing agent, symptoms, treatment and cure. the presentation focusses on the virus causing the disease, its morphology and life cycle. It has also discussed the different types of hepatitis disease and the virus causing them
This document provides information about Hepatitis A virus and Hepatitis A disease. It discusses the virus structure and properties, pathogenesis, transmission routes, clinical presentation, diagnosis, treatment, prevention including vaccination, and complications. The key points are:
- Hepatitis A virus causes an acute infectious liver disease transmitted primarily through the fecal-oral route.
- It is a non-enveloped RNA virus that is heat and acid resistant.
- After ingestion, it replicates in the liver causing inflammation and symptoms like jaundice.
- Diagnosis is based on IgM antibody detection in serum. Treatment is supportive and prevention includes vaccination and hygiene measures.
This document discusses hepatitis B virus (HBV) and hepatitis B. It defines hepatitis and the six main hepatitis viruses. It describes the structure and life cycle of HBV, including its virion structure and replication process. The document discusses the symptoms, modes of transmission, and outcomes of HBV infection. It provides global and national epidemiological data on HBV infection and details preventative measures like vaccination and immunoglobulin treatment.
Egypt has the highest prevalence of hepatitis C in the world, with an estimated 10-13% of the population testing positive for HCV antibodies. Hepatitis C genotype 4 is the most prevalent in Egypt. There are 6 known genotypes of hepatitis C worldwide. Most people with hepatitis C do not show symptoms, though acute infection can cause fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, and joint pain. Without a vaccine, prevention focuses on not sharing personal items that may transmit blood and receiving properly screened blood transfusions. Complications of chronic hepatitis C include liver scarring, cancer, and failure.
The document discusses the different types of hepatitis viruses. It states that hepatitis A, B, and C are the most common types, which can be contracted through contaminated food/water or bodily fluids. Hepatitis A has a vaccine that is given in two doses six months apart, while hepatitis B has a three dose vaccine series. There is currently no approved vaccine for hepatitis C. The document provides information on symptoms of the different hepatitis types and vaccines.
The document discusses hepatitis A-G viruses and viral hepatitis. It provides details on the transmission, clinical features, diagnosis, and prevention of hepatitis A and B viruses. Hepatitis A virus is transmitted through the fecal-oral route, has an average incubation period of 30 days, and causes an acute infection with no chronic sequelae. Hepatitis B virus can be transmitted through blood, sexual contact and perinatal transmission. It may cause either an acute infection or develop into a chronic infection associated with long-term liver problems. Laboratory tests are used to diagnose both viruses and vaccines are available to prevent infection.
Hepatitis is inflammation of the liver that can be caused by viruses, bacteria, toxins, and drugs. There are several types of hepatitis defined by their causes, which include viral types A, B, C, D, and E transmitted by fecal-oral, blood, or sexual contact; alcoholic hepatitis caused by heavy alcohol use; and toxic hepatitis due to toxins, drugs, or chemicals. Diagnosis involves liver enzyme and function tests to determine the presence and extent of liver damage. Treatment depends on the type but may include antiviral medications, immune system modulators, and avoiding further liver damage.
This document provides information about Hepatitis A Virus. It discusses that Hepatitis A is a picornavirus that infects humans and is transmitted through the fecal-oral route. While symptoms are usually mild and self-limiting, there can be complications in some cases including fulminant hepatitis. Prevention strategies include vaccination, improved sanitation and hygiene. The vaccine is effective but underutilized in many developing countries due to cost considerations.
The liver performs many essential functions, including producing chemicals and storing vitamins and minerals. Hepatitis refers to inflammation of the liver, which can be caused by viruses, alcohol, medications, and other toxins. The most common types of viral hepatitis are types A, B, and C. Hepatitis C is a serious disease that can lead to cirrhosis or liver cancer if not treated. While some people have no symptoms, others experience fatigue, abdominal pain, and jaundice. Treatment aims to eliminate the hepatitis C virus and prevent further liver damage.
Hepatitis is inflammation of the liver that can be caused by viral or non-viral factors. The major types of viral hepatitis are Hepatitis A, B, C, D, and E viruses. Hepatitis A virus causes an acute, self-limiting form of hepatitis transmitted through the fecal-oral route. Hepatitis B virus can cause both acute and chronic hepatitis and is transmitted through blood and body fluids. It is responsible for over 90% of viral hepatitis cases and is an important public health issue. Hepatitis C, D and E viruses also cause hepatitis through blood transmission but to varying degrees.
The document discusses several hepatitis viruses including types A, D, E, and G. It provides details on the classification, morphology, transmission, epidemiology, clinical manifestation, laboratory diagnosis, treatment and prevention of each virus. Hepatitis A virus causes infectious hepatitis and is transmitted via the fecal-oral route. Hepatitis D virus is defective and requires hepatitis B virus for replication. It causes more severe disease than hepatitis B alone. Hepatitis E virus causes enterically transmitted hepatitis epidemics in certain regions. Hepatitis G virus does not appear to cause hepatitis but may co-infect with other viruses like HIV.
Hepatitis is inflammation of the liver that is usually caused by a viral infection, including hepatitis A, B, C, D, E, and G viruses. The document discusses each type of viral hepatitis in terms of its discovery date, prevalence, transmission routes, prevention methods, and available treatments. For most types, vaccination and practicing good hygiene are emphasized for prevention, while treatment varies depending on the viral agent and may involve antiviral medications.
This document provides information about hepatitis C virus (HCV) including its structure, genome, genotypes, epidemiology, transmission, pathogenesis, diagnosis, and management. It discusses:
- HCV has a single-stranded RNA genome within the Flaviviridae family. It exists as different genotypes that determine treatment response.
- HCV is a major cause of liver disease worldwide, with transmission primarily through blood exposure. Diagnosis involves antibody and RNA testing.
- Treatment aims to eradicate HCV and involves pegylated interferon and ribavirin combinations. Response is monitored via viral load decline. Adverse effects require monitoring and management. New direct-acting antivirals are improving treatment outcomes.
A 45-year-old woman presented with fatigue, weakness, and appetite loss. Laboratory tests found elevated liver enzymes, bilirubin, and HCV RNA. A liver biopsy showed severe inflammation and fibrosis. She was diagnosed with hepatitis C based on her history of blood transfusion and laboratory results. Treatment with antiviral therapy is recommended to prevent further liver damage from the hepatitis C infection.
This document provides information about Hepatitis C, including how it is transmitted, symptoms, diagnosis, treatment, and prevention. Some key points:
- Hepatitis C is a contagious liver disease caused by the hepatitis C virus that can range from mild to serious and lifelong.
- It is mostly transmitted through exposure to infectious blood, such as through contaminated medical equipment or injecting drug use.
- Most infected people do not show symptoms, though some may experience fatigue, abdominal pain, and jaundice. Chronic infection can lead to cirrhosis or liver cancer.
- Diagnosis involves antibody and RNA testing to confirm. People at high risk should be screened.
- Treatment involves antiviral therapy with
Hepatitis C is a contagious liver disease that can range from a mild illness lasting a few weeks to a serious lifelong condition. Acute hepatitis C occurs within the first 6 months of exposure and often leads to chronic infection. Chronic hepatitis C can last a lifetime and significantly damage the liver, possibly causing cirrhosis or liver cancer. The virus is primarily spread through contact with infected blood and affects an estimated 3.2 million Americans, with baby boomers most at risk. While treatment is very effective at clearing the virus, hepatitis C was responsible for over 350,000 deaths worldwide in recent years.
Spread the Awareness about #Hepatitis with us on this World Hepatitis Day!
#28July #WorldHepatitisDay
*Free Shipping on all US Orders - Coupon Code "FS99"
www.OffshoreCheapMeds.co
The document summarizes hepatitis E virus (HEV), including its virology, epidemiology, transmission, clinical presentation, diagnosis, management, and prevention. HEV is an RNA virus endemic in Asia and causes acute, self-limiting hepatitis but can develop into acute liver failure, especially in pregnant women. It is transmitted primarily through contaminated food or water. Acute hepatitis E presents with jaundice and liver enzyme abnormalities and typically resolves within 1-6 weeks, though complications can include acute liver failure, chronic hepatitis may occur in immunosuppressed patients. Pregnant women are at higher risk for more severe outcomes. Management involves supportive care and chronic hepatitis may be treated with antivirals.
This document provides an introduction and overview of hepatitis classification and viruses. It discusses the following key points:
1. Hepatitis is defined as inflammation of the liver caused by viruses. There are 5 main hepatitis viruses - Hepatitis A, B, C, D, and E viruses. Hepatitis B is the only DNA virus, while the others are RNA viruses.
2. The viruses are classified based on their nucleic acid and transmitted through different routes. Hepatitis A and E are transmitted via the fecal-oral route, while Hepatitis B, C, D are blood-borne.
3. Each virus is then discussed in more detail covering features like morphology, epidemiology, pathogenesis, diagnosis, and
Hepatitis B is a viral infection that affects the liver and can become chronic. It is transmitted through bodily fluids and can range from asymptomatic to life-threatening. Around 1 million people die each year from hepatitis B complications like cirrhosis and liver cancer. While there is no cure for chronic hepatitis B, antiviral treatments can suppress the virus and prevent further liver damage. Vaccination provides highly effective protection against the disease.
Hepatitis E is a viral infection caused by the Hepatitis E virus (HEV). It is transmitted through contaminated water or food supplies and causes acute viral hepatitis. The incubation period is 2-9 weeks. Infection results in self-limiting acute hepatitis lasting several weeks, followed by recovery with no chronic cases reported. Pregnant women can experience a fulminating form with potential complications. Diagnosis is made through anti-HEV antibody levels. Prevention involves food and water hygiene precautions. There is no vaccine or specific treatment.
The presentation is about the disease, hepatitis, its causing agent, symptoms, treatment and cure. the presentation focusses on the virus causing the disease, its morphology and life cycle. It has also discussed the different types of hepatitis disease and the virus causing them
This document provides information about Hepatitis A virus and Hepatitis A disease. It discusses the virus structure and properties, pathogenesis, transmission routes, clinical presentation, diagnosis, treatment, prevention including vaccination, and complications. The key points are:
- Hepatitis A virus causes an acute infectious liver disease transmitted primarily through the fecal-oral route.
- It is a non-enveloped RNA virus that is heat and acid resistant.
- After ingestion, it replicates in the liver causing inflammation and symptoms like jaundice.
- Diagnosis is based on IgM antibody detection in serum. Treatment is supportive and prevention includes vaccination and hygiene measures.
This document discusses hepatitis B virus (HBV) and hepatitis B. It defines hepatitis and the six main hepatitis viruses. It describes the structure and life cycle of HBV, including its virion structure and replication process. The document discusses the symptoms, modes of transmission, and outcomes of HBV infection. It provides global and national epidemiological data on HBV infection and details preventative measures like vaccination and immunoglobulin treatment.
Egypt has the highest prevalence of hepatitis C in the world, with an estimated 10-13% of the population testing positive for HCV antibodies. Hepatitis C genotype 4 is the most prevalent in Egypt. There are 6 known genotypes of hepatitis C worldwide. Most people with hepatitis C do not show symptoms, though acute infection can cause fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, and joint pain. Without a vaccine, prevention focuses on not sharing personal items that may transmit blood and receiving properly screened blood transfusions. Complications of chronic hepatitis C include liver scarring, cancer, and failure.
The document discusses the different types of hepatitis viruses. It states that hepatitis A, B, and C are the most common types, which can be contracted through contaminated food/water or bodily fluids. Hepatitis A has a vaccine that is given in two doses six months apart, while hepatitis B has a three dose vaccine series. There is currently no approved vaccine for hepatitis C. The document provides information on symptoms of the different hepatitis types and vaccines.
The document discusses hepatitis A-G viruses and viral hepatitis. It provides details on the transmission, clinical features, diagnosis, and prevention of hepatitis A and B viruses. Hepatitis A virus is transmitted through the fecal-oral route, has an average incubation period of 30 days, and causes an acute infection with no chronic sequelae. Hepatitis B virus can be transmitted through blood, sexual contact and perinatal transmission. It may cause either an acute infection or develop into a chronic infection associated with long-term liver problems. Laboratory tests are used to diagnose both viruses and vaccines are available to prevent infection.
El documento describe la etiología, epidemiología, diagnóstico, patogenia, manifestaciones clínicas, tratamiento y prevención de las hepatitis A, B, C, D y E. Las hepatitis virales son causadas por los virus de hepatitis A, B, C, D y E y se transmiten principalmente por vía enteral, parenteral o sexual. El diagnóstico incluye evaluación clínica, pruebas de laboratorio y en algunos casos biopsia hepática. El tratamiento depende del tipo de hepatitis viral y puede incluir interferón, antivirales y soporte sint
A. The document discusses viral hepatitis, providing information on the different types of hepatitis viruses (A, B, C, D, E). It describes the viruses' characteristics such as their structure, incubation period, transmission route, and ability to cause chronic infection.
B. Diagnosis of the hepatitis viruses involves detecting viral antigens, antibodies, RNA, or DNA in blood or liver tissue. Some types like hepatitis A can be prevented through vaccination and hygiene practices. Treatment focuses on suppressing viral replication through antiviral drugs.
C. While most hepatitis viruses cause acute, self-limiting illness, hepatitis B and C frequently result in chronic infection and long-term complications like cirrhosis if left untreated.
HEPATITIS - Treatment And Prevention (Ayurvedic concept)Abhilash Mu
A detailed and small slide on the treatment and prevention measures of hepatitis according to AYURVEDIC concept .The slide explains in brief about the primary and secondary prevention measures for hepatitis a and hepatitis b and also their treatment principles according to ayurveda .
Hepatitis C is a virus that can harm the liver. It is usually spread through blood-to-blood contact, such as from an infected mother to her baby during birth or from sharing needles. While hepatitis C may not cause symptoms in children, regular checkups are important to monitor liver health. There is no way for a mother to prevent passing hepatitis C to her baby. The virus can remain in the body for life, though medications exist as a cure once one is an adult.
Hepatitis B virus (HBV) infects the liver and can cause both acute and chronic infection. It is transmitted through contact with infectious blood or body fluids and can potentially lead to cirrhosis and liver cancer. While there is no cure for chronic HBV infection, treatment can suppress viral replication and prevent progression of liver disease. HBV infection is preventable through vaccination, which provides over 90% protection for newborns when given with antibodies within 12 hours of birth.
laboratory diagnosis of viral hepatitis (B & C)PathKind Labs
This document discusses diagnostic evaluation of viral hepatitis. It provides an overview of hepatitis, describing it as inflammation of the liver that can be caused by infectious viruses, bacteria, fungi, parasites, or non-infectious factors like alcohol, drugs or metabolic diseases. The major hepatotropic viruses that cause hepatitis - hepatitis A, B, C, D and E viruses - are described. The document also discusses a case study of a patient presenting with symptoms of hepatitis and the appropriate serological tests to order. It provides guidance on interpreting the test results and diagnosing the type of hepatitis.
Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...Jack Frost
The document provides an overview of the seven main types of viral hepatitis (A, B, C, D, E, F, G). It summarizes the key characteristics of each type including causative virus, transmission route, risk factors, symptoms, diagnosis, severity, and prevention methods. Normal liver enzyme and function test results are also listed for reference in assessing liver problems.
The document describes three case studies of patients presenting with hepatitis. The first case involves a man who returned from Thailand with fatigue, nausea and abdominal discomfort. The second case is a pregnant woman who was a former heroin addict and had shared needles. The third case is a man who developed jaundice six months after coronary bypass surgery. The document then provides information about hepatitis A, B and C viruses, including their structures, modes of transmission, clinical presentations and approaches to diagnosis.
George, a 62-year-old farmer, presents with fatigue and yellowing of the eyes for 2 weeks. He reports weight loss but no other symptoms. Laboratory tests show elevated bilirubin and liver enzymes with positive hepatitis B surface antigen. The doctor considers diagnoses including acute or chronic hepatitis B, alcoholic liver disease, and other causes of jaundice. A liver biopsy may be needed to confirm chronic hepatitis B as the cause of the patient's chronic condition and symptoms.
Hepatitis viral (A,B,C,D,E,F,G) (2012) Eric Ardiles
Este documento describe las diferentes causas de hepatitis, incluyendo 7 virus hepatotropicos (A, B, C, D, E, F, G) que pueden causarla. Explica las características de cada virus como su tamaño, familia y genoma, así como su epidemiología, manifestaciones clínicas, diagnóstico, tratamiento y prevención. Resalta que la hepatitis es prevenible a través de la educación y vigilancia comunitaria.
La hepatitis es una inflamación del hígado que puede ser causada por virus, alcohol u otras toxinas. Existen varios virus de la hepatitis, incluyendo los virus A, B, C, D y E. Cada uno se transmite de manera diferente y puede causar una infección aguda o crónica. Los síntomas incluyen ictericia, prurito, náuseas y vómitos. Algunos casos no presentan ictericia.
Este documento describe los virus de la hepatitis A, B, C y D. Resume sus características generales como su estructura, replicación, patogenia, epidemiología y enfermedades clínicas. Explica cómo se diagnostican en el laboratorio y los tratamientos disponibles para cada virus.
There are five main types of viral hepatitis: A, B, C, D, and E. Hepatitis B and C often cause chronic infections that can lead to cirrhosis and liver cancer, resulting in approximately 1 million deaths annually worldwide. An estimated 2 billion people have been infected with hepatitis B virus and 150 million are chronically infected with hepatitis C virus. Transmission of hepatitis B and C occurs primarily through contact with contaminated blood or body fluids. The WHO is working to increase prevention, testing, treatment and policy efforts to address the growing burden of viral hepatitis globally.
Hepatitis B is a viral infection that affects the liver and can cause both acute and chronic disease. It is transmitted through bodily fluids and is preventable through vaccination. Acute hepatitis B usually clears up on its own within 6 months, while chronic hepatitis B can last a lifetime if left untreated. Complications of chronic hepatitis B include cirrhosis, liver cancer, and liver failure. Hepatitis B is a major global health problem and vaccination is the most effective way to prevent its spread.
Este documento resume la hepatitis viral aguda y autoinmune. Describe las diferentes hepatitis virales (HAV, HBV, HCV, HDV, HEV) que producen infecciones generalizadas que afectan principalmente el hígado y causan enfermedades similares a pesar de sus diferencias. Se enfoca en la hepatitis A, describiendo su epidemiología, manifestaciones clínicas, diagnóstico, complicaciones, profilaxis y tratamiento. Finalmente, analiza la hepatitis autoinmune, discutiendo su etiología, presentación clínica, criterios diagnósticos
Hepatitis C virus causes hepatitis C, an inflammation of the liver. It is a small enveloped RNA virus that is transmitted through exposure to infectious blood, such as receiving contaminated blood transfusions, injections with unclean needles, or from an infected mother to her baby during childbirth. There is currently no vaccine for hepatitis C, but chronic cases are treated with pegylated interferon and ribavirin medications. New oral protease inhibitor drugs are also being used to treat genotype 1 hepatitis C infections.
This document provides an overview of hepatitis, including:
- Definitions of acute and chronic hepatitis and their causes such as various viruses and toxins.
- Clinical features such as jaundice, fever, and complications like cirrhosis.
- Investigations including liver function tests and viral serology.
- Prevention through vaccines for hepatitis A and B.
- Treatment options for different types of hepatitis such as antiviral drugs for hepatitis B and C and steroids for autoimmune hepatitis.
The document provides information about Hepatitis A and Hepatitis B viruses including:
1. Hepatitis A virus is transmitted through the fecal-oral route while Hepatitis B can be transmitted through contact with infected blood or bodily fluids.
2. Hepatitis A infection causes an acute illness that does not lead to chronic infection or liver disease. Hepatitis B can result in either an acute or chronic infection, with chronic infection putting one at risk of serious liver diseases.
3. Diagnosis of Hepatitis A is usually based on detecting IgM antibodies in serum while Hepatitis B involves blood tests to detect hepatitis B surface antigen and specific antibodies.
The document discusses hepatitis, an inflammation of the liver that can be caused by infectious or noninfectious reasons. The most common causes are hepatitis viruses A, B, C, D, and E. Hepatitis A is highly contagious and spreads through the fecal-oral route or contaminated food/water. Hepatitis B spreads through blood or bodily fluids and can result in acute or chronic infection. Hepatitis C is a major cause of chronic blood-borne infection spread through intravenous drug use or birth from an infected mother. Symptoms include jaundice, abdominal pain, and fatigue. Diagnosis involves clinical evaluation and serologic tests. Treatment focuses on rest, nutrition, vaccination, and drug therapy depending on the hepatitis
The document discusses hepatitis, an inflammation of the liver that can be caused by infectious or noninfectious reasons. The most common causes are hepatitis viruses A, B, C, D, and E. Hepatitis A is highly contagious and spreads through the fecal-oral route or contaminated food/water. Hepatitis B spreads through blood or bodily fluids and can result in acute or chronic infection. Hepatitis C is a major cause of chronic bloodborne infection spread through intravenous drug use or birth from an infected mother. Symptoms include jaundice, abdominal pain, and fatigue. Diagnosis involves clinical evaluation and serologic tests. Treatment focuses on rest, nutrition, vaccination, and drug therapy depending on the hepatitis type
Acute hepatitis can be caused by viruses, toxins, drugs, or autoimmune processes. The most common causes are viral hepatitis A, E, B, C, and D. Hepatitis A and E are usually self-limiting and do not result in chronic liver disease. Hepatitis B, C, and D can become chronic, increasing the risk of cirrhosis and liver cancer. Symptoms of acute hepatitis include fatigue, nausea, abdominal pain, and jaundice. Treatment focuses on relieving symptoms; vaccination helps prevent hepatitis A and B. Complications can include liver failure, chronic liver disease, or aplastic anemia.
Acute hepatitis refers to inflammation of the liver that lasts less than six months. It is commonly caused by viral infections such as hepatitis A, B, C, D, and E, but can also be due to other infections, toxins like alcohol, drugs, or autoimmune processes. Symptoms may include fatigue, nausea, vomiting, abdominal pain, and jaundice. Liver enzymes are elevated and viral markers can help identify the cause. Most cases of acute hepatitis are self-limiting, but some may lead to chronic liver disease. Treatment focuses on relieving symptoms, and vaccination can help prevent viral hepatitis.
Hepatitis A is an acute infectious disease of the liver caused by the hepatitis A virus. It is transmitted through ingestion of contaminated food or water or direct contact with an infected person. Symptoms include fatigue, fever, abdominal pain, and jaundice. There is no treatment, but vaccination provides effective prevention.
This document discusses several types of hepatitis viruses. It covers hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus, and hepatitis E virus. For each virus, it describes key aspects such as transmission, pathogenesis, clinical manifestations, diagnosis, and prevention. Hepatitis viruses can cause liver inflammation and damage, and some may lead to chronic infection or liver cancer if not addressed. Vaccines exist to prevent hepatitis A and B.
Hepatitis A is an enterically transmitted viral infection that causes inflammation of the liver. It is typically self-limited and does not result in chronic infection. The virus is shed in the feces during the incubation period and patients are most infectious prior to the onset of symptoms. Diagnosis is made by detecting IgM antibodies to Hepatitis A virus. There is no specific treatment, so management focuses on supportive care and prevention of transmission through hand hygiene and vaccination.
The document discusses several hepatitis viruses including hepatitis A, B, C, D, and E. It provides details on the structure and classification of the viruses. The major modes of transmission are discussed as the fecal-oral route for hepatitis A and exposure to infected blood or bodily fluids for hepatitis B and C. The clinical manifestations of infection typically involve inflammation of the liver and can range from an asymptomatic infection to life-threatening disease. Laboratory tests are outlined for diagnosing active infection and immunity. Prevention methods include vaccination, blood screening, and harm reduction practices.
Hepatitis is an inflammation of the liver that can range from self-limiting to leading to serious conditions like fibrosis, cirrhosis, or liver cancer. There are 5 main hepatitis viruses (A, B, C, D, and E) that are the most concerning due to illness burden and epidemic potential. Hepatitis B and C are the most common causes of liver disease worldwide and can result in chronic infection for hundreds of millions of people. Transmission of hepatitis B, C, and D usually occurs through contact with infected body fluids, while hepatitis A and E are typically transmitted through contaminated food or water. Effective vaccines exist for hepatitis A and B but not for hepatitis C, D, or E.
This document discusses hepatitis B virus (HBV) and hepatitis B. It defines hepatitis and the six main hepatitis viruses. It describes the structure and life cycle of HBV, including its virion structure and replication process. The document discusses the symptoms, modes of transmission, and outcomes of HBV infection. It provides global and national epidemiological data on HBV infection and details preventative measures like vaccination and immunoglobulin treatment.
This document discusses hepatitis B virus (HBV) and hepatitis B. It defines hepatitis and the six main hepatitis viruses. It describes the structure and life cycle of HBV, including its virion structure and replication process. The document discusses the symptoms, modes of transmission, and outcomes of HBV infection. It provides global and national epidemiological data on HBV infection and details preventative measures like vaccination and immunoglobulin treatment.
Hepatitis is inflammation of the liver that can be caused by viruses, alcohol, drugs, toxins, and autoimmune diseases. There are 5 main types of viral hepatitis: Hepatitis A, B, C, D, and E. Hepatitis A and E are typically acute but Hepatitis B, C, and D can be acute or chronic. Chronic hepatitis B and C can lead to cirrhosis and liver cancer. Treatment depends on the cause but involves rest, proper nutrition, fluid maintenance, immunoglobulins, antivirals, and vaccination. Patient education focuses on prevention, risk factors, and symptom monitoring.
Hepatitis is inflammation of the liver that can be caused by viruses, alcohol, drugs, toxins and autoimmune diseases. There are 5 main types of viral hepatitis: Hepatitis A, B, C, D and E. Hepatitis A and E are typically acute but Hepatitis B, C and D can be acute or chronic. Chronic hepatitis B and C can lead to cirrhosis and liver cancer. Symptoms are similar to the flu. Treatment depends on the cause but involves rest, proper nutrition, fluid maintenance and medications to treat the virus in some cases. Education is important to prevent transmission.
This document provides an overview of the different types of viral hepatitis: A, B, C, D, and E. It describes the causes, transmission methods, symptoms, laboratory diagnosis, treatment, and prevention of each type. Hepatitis A is usually transmitted by consuming contaminated food or water, while hepatitis B, C and D can be transmitted through contact with infectious body fluids. Hepatitis B and C often result in chronic infections while hepatitis A typically resolves on its own without treatment. Vaccination and improved sanitation can help prevent the spread of the different hepatitis viruses.
This document contains information about Hepatitis B from multiple contributors. It discusses how Hepatitis B is caused by a virus that infects the liver, its typical transmission routes like contact with infected blood or bodily fluids, and potential long term effects like liver damage or cancer. It also provides an overview of the signs and symptoms of Hepatitis B infection, how the vaccine is produced using genetic engineering techniques, and the different causes and transmission routes for Hepatitis A, B, C, D and E.
Hepatitis B is a viral infection of the liver caused by the hepatitis B virus that can lead to liver failure, cirrhosis, or liver cancer. It is transmitted through contact with infected blood or bodily fluids and common symptoms include fever, fatigue, nausea and jaundice. The hepatitis B virus is 100 times more infectious than HIV. While there is no cure for chronic hepatitis B infection, prevention through vaccination and treatment for those infected can help control the disease.
Hepatitis is an inflammation of the liver that is usually caused by a viral infection. There are 5 main types of viral hepatitis: A, B, C, D, and E. Hepatitis A and E are typically transmitted through ingestion of contaminated food or water. Hepatitis B, C and D can be transmitted through contact with infected blood or bodily fluids. While hepatitis A only causes a short-term illness, hepatitis B and C can develop into chronic conditions that lead to serious liver problems like cirrhosis and cancer. Laboratory tests are used to diagnose hepatitis and detect the specific virus, and nursing care focuses on rest, diet, medication management, and health education to prevent transmission and complications.
Hepatitis is generally refer to inflammation of liver, it is resulted from infectious causes (such as viral, bacterial and fungal causes ) or noninfectious ( such as alcohol drugs, autoimmune diseases and metabolic diseases) , in this research , I’m going to focus on viral hepatitis because it is the most common cause of acute hepatitis in USA ( 50% of cases ).
The commonness and important viruses that cause viral hepatitis are (A,B,C,D,E) types, approximately 4.4 million Americans are currently living with chronic hepatitis B and C.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
2. What is HEPATITIS ?
Hepatitis refers to an
inflammatory
condition of the liver
commonly caused by a viral infection
3. There are 5 main hepatitis viruses, referred to as
types A, B, C, D and E. These 5 types are of
greatest concern because of the burden of
illness and death they cause and the potential
for outbreaks and epidemic spread ..
4.
5. Hepatitis A and E are typically caused by ingestion of contaminated food or
water. Hepatitis B, C and D usually occur as a result of parenteral contact
with infected body fluids. Common modes of transmission for these viruses
include receipt of contaminated blood or blood products, invasive medical
procedures using contaminated equipment and for hepatitis B transmission
from mother to baby at birth, from family member to child, and also by
sexual contact.
Acute infection may occur with limited or no symptoms, or may include
symptoms such as jaundice (yellowing of the skin and eyes), dark urine,
extreme fatigue, nausea, vomiting and abdominal pain.
6. Alcohol
Hepatitis can be caused by liver damage from excessive
alcohol consumption. This is sometimes referred to as alcoholic
hepatitis. The alcohol causes the liver to swell and become
inflamed. Other toxic causes include overuse of medication or
exposure to poisons.
Autoimmune Disease
The immune system may mistake the liver as a harmful object
and begin to attack it, hindering liver function.
Causes of Non-viral Hepatitis
7. The condition can be self-limiting or
can progress to fibrosis (scarring),
cirrhosis or liver cancer .
16. Hepatitis A virus (HAV) is present in the faeces of infected
persons and is most often transmitted through consumption of
contaminated water or food. Certain sex practices can also
spread HAV. Infections are in many cases mild, with most
people making a full recovery and remaining immune from
further HAV infections. However, HAV infections can also be
severe and life threatening. Most people in areas of the world
with poor sanitation have been infected with this virus. Safe and
effective vaccines are available to prevent HAV.
HAV
17. No treatment is needed for hepatitis A since the
infection almost always resolves on its own. Nausea is
common, though transient, and it is important to stay
hydrated. It is recommended that strenuous exercise
be avoided until the acute illness is over.
18. Hepatitis B virus (HBV) is transmitted through exposure to
infective blood, semen, and other body fluids. HBV can be
transmitted from infected mothers to infants at the time of birth
or from family member to infant in early childhood. Transmission
may also occur through transfusions of HBV-contaminated
blood and blood products, contaminated injections during
medical procedures, and through injection drug use. HBV also
poses a risk to healthcare workers who sustain accidental
needle stick injuries while caring for infected-HBV patients. Safe
and effective vaccines are available to prevent HBV.
HBV
19. For hepatitis B, treatment is aimed at controlling the
virus and preventing damage to the liver. Antiviral
medications are available that will benefit most
people, but the medications need to be chosen
carefully, and the treatment needs to be monitored in
order to assure successful treatment and prevent or
treat medication-related side effects. For some
individuals, the risks of treatment may not be justified.
20. Hepatitis C virus (HCV) is mostly transmitted through exposure to
infective blood. This may happen through transfusions of HCV-
contaminated blood and blood products, contaminated
injections during medical procedures, and through injection
drug use. Sexual transmission is also possible, but is much less
common. There is no vaccine for HCV.
HCV
23. Treatment of chronic hepatitis C has evolved, rendering many
earlier drugs obsolete. The drugs currently used (as of March
2016) include pegylated interferon, ribavirin, elbasvir,
grazoprevir, ledipasvir, sofosbuvir, paritaprevir, ritonavir,
ombitasvir, dasabuvir, simeprevir, daclatasvir. These are always
used in various combinations, never alone. Interferon is given by
injection while the other medications are pills. Studies have
shown that combinations of these drugs can cure all but a small
proportion of patients; however, serious side effects of
treatment can occur.
24. Hepatitis D virus (HDV) infections occur only in those who are
infected with HBV. The dual infection of HDV and HBV can result
in a more serious disease and worse outcome. Hepatitis B
vaccines provide protection from HDV infection.
HDV
25. Hepatitis E virus (HEV) is mostly transmitted through consumption
of contaminated water or food. HEV is a common cause of
hepatitis outbreaks in developing parts of the world and is
increasingly recognized as an important cause of disease in
developed countries. Safe and effective vaccines to prevent
HEV infection have been developed but are not widely
available.
HEV
26. Although structurally quite different, the Hepatitis Viruses produce similar
morphological and clinical pictures. Three basic clinico-pathological
pictures can develop depending on the timescale of infection which is
largely determined by the exuberance of the immune response to the virus.
oClinico-pathological Patterns
• Acute Viral Hepatitis : Strong Immune Response
• Chronic Viral Hepatitis : Absent or Low Immune Response
• Fulminant Hepatitis : Catastrophically exuberant immune response
27. Acute Viral Hepatitis refers to a clinico-pathological
pattern of disease caused by infection with Hepatitis
Viruses that results in short-term inflammation
of the liver.
Definition
Acute Viral Hepatitis
28. Infection with any of the Hepatitis Viruses (HAV, HBV,
HCV, HDV) can initiate acute viral hepatitis.
Generally speaking, HAV only produces acute viral
hepatitis, HBV produces acute syndromes in adults
but rarely when infection occurs in infants, and HCV
produces acute syndromes in a minority of cases.
Etiologies
Acute Viral Hepatitis
29. • Gross Appearance
The liver may be enlarged and slightly reddened.
• Histological Appearance
Hepatocytes respond to injury in a number of ways including cytoplasmic
vacuolation (Termed "Ballooning Degeneration"), cellular rupture, or simply
apoptosis. In severe cases, areas of hepatic tissue may undergo necrosis. The
hepatic tissue displays striking inflammation in acute viral hepatitis which
manifests with proliferation of kupffer cells as well as parenchymal infiltration
with mononuclear cells, especially lymphocytes. Within this inflammatory war
zone, areas of hepatocyte regeneration can be observed. Finally, in the case
of HBV infection, the cytoplasm of hepatocytes may appear full of granules,
giving them a characteristic "Ground-Glass Appearance", representing dense
granules of HBV Surface Antigen (HBsAg).
Morphology
Acute Viral Hepatitis
31. • Incubation Period
All of the Hepatitis Viruses possess an incubation period
where there is no clinical or serological evidence of
infection. The incubation periods vary for each virus but
generally last between one to two months.
Classic Clinical Syndrome
Acute Viral Hepatitis
32. • Prodrome
The prodromal period is characterized by nonspecific
symptoms associated with systemic infection. The prodrome
characterizes rapid viral proliferation prior to the development
of an immune response. During this period serological markers
of viral proteins as well as serum aminotransferase (ALT and AST)
levels will skyrocket. Clinically, constitutional symptoms along
with malaise, fatigue, and anorexia may be present.
Classic Clinical Syndrome
Acute Viral Hepatitis
33. • Icteric Phase
During this phase clinical signs of jaundice and scleral icterus
will appear and some right upper quadrant tenderness may
develop due to enlargement of the liver. However, this phase
coincides with a building immune response which begins to
bring the virus under control .
During this period IgM antibodies to certain viral antigens begin
to develop and viral protein levels will decline. Constitutional
symptoms also decrease in intensity and serum
aminotransferases begin to fall.
Classic Clinical Syndrome
Acute Viral Hepatitis
34. • Recovery Phase
During this phase clinical signs of jaundice subside as
do most constitutional symptoms. The immune
response also matures and many of the anti-viral IgM
antibodies begin to class switch to the IgG subtype.
Levels of serum aminotransferases also return to
normal.
Classic Clinical Syndrome
Acute Viral Hepatitis
35. Chronic Viral Hepatitis refers to a clinico-pathological
pattern of disease caused by infection with certain
Hepatitis Viruses that results in greater than 6 months
of hepatic inflammation and injury .
Definition
Chronic Viral Hepatitis
36. • Hepatitis A Virus
Almost never results in chronic infection.
• Hepatitis B Virus
If transmission occurs in neonates via mother-to-child transmission: Nearly 99% of individuals
display chronic infection
If transmission occurs in immunocompetent adults: Only 1% of individuals display chronic
infection
If transmission occurs in immunocompromised adults: Rate of chronic infection is significantly
higher than 1%
• Hepatitis C Virus
Nearly 80% of infected adults will display chronic infection.
• Hepatitis D Virus
If acquired through co-infection with HBV, follows same pattern as HBV. If
acquired on top of chronic HBV infection, will result in chronic HDV infection.
Etiology
Chronic Viral Hepatitis
37. Long-term infection with hepatitis viruses results in variable
degrees of low-grade inflammation. In many cases,
inflammation is so minute and pathological changes so
nuanced that clinical consequences are not observed. In
other cases, inflammation smolders sufficiently that over
time extensive fibrosis is observed that ends in a picture of
cirrhosis. Finally, in some individuals the immune system may
suddenly and spontaneously mount a stronger response to
the virus leading to a syndrome of acute viral hepatitis.
Pathogenesis
Chronic Viral Hepatitis
38. The morphology of chronic hepatitis is extremely variable.
When mild, a predominantly lymphocytic infiltrate may
occur just within the portal tracts. Frequently, steatosis is
observed along with lymph node-like aggregations within
the hepatic parenchyma
When severe, hepatocyte necrosis may be apparent.
Progression to cirrhosis is manifested by increasing fibrosis.
Morphology
Chronic Viral Hepatitis
39. Fulminant Hepatitis is a complication of
acute viral hepatitis that manifests as
rapid functional decompensation of
the liver.
Definition
Fulminant Hepatitis
40. Fulminant Hepatitis occurs in the context of
acute viral hepatitis. It is rare during hepatitis
A or C virus infection. Most cases are due to
Hepatitis B Virus infection with or without
Hepatitis D Virus. It is most likely the result of
a massive, overly-exuberant immune
response to the presence of virus, resulting in
rapid inflammatory damage to the liver.
Etiology and Pathogenesis
Fulminant Hepatitis
41. • Overview
Fulminant Hepatitis is characterized by certain signs of hepatic failure that can
manifest rapidly and thus does not include those that require chronic timescales to
develop.
• Symptomology
Hepatic Encephalopathy: Characterized by altered mental status, confusion, somnolence, or coma
Brain Edema: May occur, possibly resulting in cerebral herniation
Hepatorenal Syndrome: Which may result in acute renal failure
Generalized Edema: Due to rapid hypoalbuminemia
Prolonged Prothrombin Time (PT) : Due to reduced synthesis of coagulation proteins
Jaundice: Due to hyperbilirubinemia
ARDS may result
• Prognosis
Fulminant Hepatitis has a high degree of mortality and is rapidly fatal.
Clinical Consequences
Fulminant Hepatitis
42. Very frequently the onset of hepatitis, the acute phase, is not
associated with symptoms or signs, but when they do occur
they are usually general and include fatigue, nausea,
decreased appetite, mild fever, or mild abdominal pain.
Later signs more specific for liver disease may occur,
specifically yellowing of the skin and eyes (jaundice) and
darkening of the urine. If the infection becomes chronic as is
the cause with hepatitis B and C, that is, lasting longer than
months, the symptoms and signs of chronic liver disease may
begin. At this point the liver often is badly damaged.
Symptoms of Hepatitis
43.
44.
45. How Is Hepatitis Diagnosed ?
Physical Exam
Liver Biopsy
Liver Function Tests
Ultrasound
Blood Tests
Viral Antibody Testing